Biological age after bariatric surgery: mortality-linked marker in 505 patients
In a prospective cohort of 505 bariatric surgery patients, a mortality-associated biological age measure was on average 5.55 years lower 12 months after surgery and stayed stable to 24 months; adjusting for body mass index change left 3.32 years, suggesting an effect beyond weight loss. [1]
Automatic summary · not editorially reviewed
The key findings
In a prospective cohort of 505 patients undergoing bariatric surgery, biological age was modelled from established blood markers, and age acceleration was evaluated at different time points with mixed effects models. [1]
Twelve months after surgery, patients were on average 5.55 years younger by this measure, stable until 24 months; adjusting for body mass index change left 3.32 years at 12 months. [1]
The abstract concludes that biological age was markedly reduced, corresponding to a 40–50% reduction in expected mortality after two years, particularly in men. [1]
The source at a glance
- Study type / format
- Prospective cohort study (abstract only).
- Population / context
- 505 patients who underwent bariatric surgery in a prospective cohort.
- Summary based on
- Study abstract
- Original publication
- June 19, 2026
Biological age modelled from blood markers in 505 patients
The abstract describes a prospective cohort of 505 patients who underwent bariatric surgery. Biological age was modelled from established blood markers, and the difference between biological age and chronological age (age acceleration) was treated as a molecular marker of health gain. Measurements were taken at different time points and analysed with mixed effects models. At baseline, greater biological age acceleration was positively correlated with higher smoking exposure and increased body mass, particularly in males. The abstract does not name the individual markers used in the model beyond examples given later.
Supporting source [1]
5.55 years younger at 12 months, 3.32 after BMI adjustment
Twelve months after surgery, patients were on average 5.55 years younger by this measure (95% confidence interval -6.12 to -4.97), and this remained stable until 24 months. When the analysis was adjusted for changes in body mass index over time, the decrease was 3.32 years at 12 months (95% confidence interval -4.26 to -2.37). The abstract interprets this as an age-rejuvenating effect beyond weight loss, more pronounced in men. Individual markers contributing to the computation, such as glucose, C-reactive protein and blood cell counts, generally changed more favourably after surgery. The abstract concludes that biological age was markedly reduced, corresponding to a 40–50% reduction in expected mortality after two years, particularly in men.
Supporting source [1]
Abstract-only scope: associations, not proven causes
This explainer is based only on the abstract; the full text was not reviewed. The design is a prospective cohort without a stated comparison group, so the observed changes are associations over time and do not by themselves prove that surgery caused them. The 40–50% reduction in expected mortality is a modelled figure derived from the biological age measure, not an observed count of deaths in the study. The abstract does not report follow-up beyond 24 months, the exact marker panel, or how the mortality model was built.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. Prospective cohort without a stated comparison group; changes are associations over time. The 40–50% mortality reduction is modelled from the biological age measure, not observed deaths. Follow-up beyond 24 months, the full marker panel and model details are not reported in the abstract.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Morawitz KH, Pommer W, Tsuprykov O, Krautschneider H, von Germar S, Patzke N, Grassmann F. · europepmc.org · June 19, 2026